Phenoxybenzamine hydrochloride
- Product NDC
- 60219-1502
- 11-digit product format
- 602191502
- Labeler code
- 60219
- Product ID
- 60219-1502_f872082d-e917-4945-9cd8-59c082cd32d8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phenoxybenzamine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA212568
- Marketing category
- ANDA
- Marketing start
- 2020-10-30
- Substance
- PHENOXYBENZAMINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phenoxybenzamine hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENOXYBENZAMINE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X1IEG24OHL |
| Rxcui | 861402 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60219-1502-1 | Phenoxybenzamine hydrochloride | 100 in 1 BOTTLE | CAPSULE | 100 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60219-1502 | PHENOXYBENZAMINE HYDROCHLORIDE CAPSULE [AMNEAL PHARMACEUTICALS NY LLC] | 11 | Current NDC, Legacy NDC, 1 package rows | 20240117_0be6a394-cd10-42fc-97cf-ad53d81d8d93.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60219-1502-1 | 60219150201 | 100 CAPSULE in 1 BOTTLE (60219-1502-1) | 100 capsule | 2020-10-30 | 0000-00-00 | No | No | Current |